PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 7(1): 29-31 1987
© 1987 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gagnon, R. F.
Right arrow Articles by Kaye, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gagnon, R. F.
Right arrow Articles by Kaye, M.

REVIEWS AND ORIGINAL ARTICLES

ß2-MICROGLOBULIN SERUM LEVELS IN PATIENTS ON LONG TERM DIALYSIS

Raymonde France Gagnon, Peter Somerville and Michael Kaye

From the Division of Nephrology, Department of Medicine, Montreal General Hospital, McGill University, Montreal, Canada.

Recently several workers have described a ß2-microglobulin-containing amyloid in patients on chronic hemodialysis. We have demonstrated that, in terms of the degree of elevation and the absence of correlation with duration of dialysis, the ß2-microglobulin serum levels of CAPD patients are comparable to those on hemodialysis. Thus all dialysis patients seem to bear an increasing risk of tissue deposition of ß2-microglobulin in the form of the newly-described amyloid, and this risk appears to be independent of the mode and duration of dialysis.

KEY WORDS: ß2-microglobulin; Amyloid; Carpal tunnel syndrome.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1987 by Multimed Inc.